Literature DB >> 2363245

Immunochemical studies of oligosaccharides obtained from the lipopolysaccharide of Brucella ovis.

C E Suarez1, G A Pacheco, A M Vigliocco.   

Abstract

Brucella ovis rough lipopolysaccharide (R-LPS) was studied with respect to its heterogeneity, chain length, sugar composition and immunological activity. R-LPS was mildly hydrolysed and oligosaccharides were recovered in the upper phase after partition with chloroform-methanol. Gel-filtration of the upper phase in a column of Bio-Gel P-2 yielded oligosaccharides of 2, 4, 6 and 7 monosaccharide units, 2-keto-deoxy-octulosonic acid (KDO), and monosaccharides. Strong acid hydrolysis followed by paper chromatography showed that the hexa- and heptasaccharides are both composed of glucose, KDO and an unidentified sugar while tetrasaccharide is composed of glucose, mannose and glucosamine. These three oligosaccharides were able to inhibit the LPS-antibody reaction in a solid phase radioimmunoassay, suggesting the oligosaccharides bear antigenic determinants of LPS.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2363245     DOI: 10.1016/0378-1135(90)90019-r

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  3 in total

1.  Brucella abortus and its closest phylogenetic relative, Ochrobactrum spp., differ in outer membrane permeability and cationic peptide resistance.

Authors:  J Velasco; J A Bengoechea; K Brandenburg; B Lindner; U Seydel; D González; U Zähringer; E Moreno; I Moriyón
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

2.  Brucella abortus rough mutants are cytopathic for macrophages in culture.

Authors:  Jianwu Pei; Thomas A Ficht
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

3.  Mutants in the lipopolysaccharide of Brucella ovis are attenuated and protect against B. ovis infection in mice.

Authors:  Pedro Soler-Lloréns; Yolanda Gil-Ramírez; Ana Zabalza-Baranguá; Maite Iriarte; Raquel Conde-Álvarez; Amaia Zúñiga-Ripa; Beatriz San Román; Michel S Zygmunt; Nieves Vizcaíno; Axel Cloeckaert; María-Jesús Grilló; Ignacio Moriyón; Ignacio López-Goñi
Journal:  Vet Res       Date:  2014-07-17       Impact factor: 3.683

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.